| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,470,213 |
1,239,327 |
$79.85M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
604,216 |
504,548 |
$27.06M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
230,143 |
194,573 |
$16.84M |
| 87428 |
|
258,495 |
171,134 |
$12.77M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
984,351 |
443,253 |
$10.95M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
301,000 |
258,188 |
$9.49M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
219,342 |
190,726 |
$6.81M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
106,855 |
89,012 |
$6.11M |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
552,602 |
483,677 |
$4.86M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
197,597 |
163,833 |
$2.18M |
| 96127 |
|
126,006 |
106,159 |
$616K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
6,054 |
5,117 |
$270K |
| 87807 |
|
27,842 |
24,393 |
$231K |
| 99215 |
Prolong outpt/office vis |
2,667 |
2,193 |
$189K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
3,189 |
2,642 |
$174K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
31,803 |
27,446 |
$117K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,628 |
1,903 |
$117K |
| 99051 |
|
11,269 |
10,280 |
$94K |
| 81003 |
|
67,115 |
57,678 |
$89K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,670 |
1,720 |
$72K |
| Q3014 |
Telehealth originating site facility fee |
3,757 |
3,356 |
$56K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,936 |
1,108 |
$55K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
96,116 |
82,383 |
$55K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,207 |
594 |
$39K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
22,436 |
18,934 |
$34K |
| 17110 |
|
774 |
561 |
$25K |
| 99205 |
Prolong outpt/office vis |
277 |
221 |
$22K |
| 71046 |
Radiologic examination, chest; 2 views |
2,663 |
2,367 |
$21K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,153 |
315 |
$18K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
858 |
713 |
$15K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,791 |
10,125 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
7,690 |
6,180 |
$12K |
| 81025 |
|
4,300 |
3,790 |
$12K |
| 90791 |
Psychiatric diagnostic evaluation |
374 |
315 |
$12K |
| 90837 |
Psychotherapy, 53 minutes with patient |
209 |
122 |
$12K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,182 |
1,912 |
$12K |
| 95117 |
|
488 |
161 |
$11K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
968 |
240 |
$10K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,645 |
3,076 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
227 |
210 |
$9K |
| 99401 |
|
709 |
363 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
330 |
252 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
100 |
89 |
$6K |
| 90688 |
|
222 |
214 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
85 |
80 |
$5K |
| 93000 |
|
909 |
824 |
$5K |
| 73630 |
|
868 |
778 |
$5K |
| 73610 |
|
824 |
715 |
$4K |
| 80305 |
|
311 |
229 |
$3K |
| 86308 |
|
2,336 |
2,071 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
139 |
116 |
$3K |
| 73130 |
|
533 |
474 |
$3K |
| 12001 |
|
44 |
40 |
$2K |
| 73110 |
|
466 |
413 |
$2K |
| 20611 |
|
48 |
27 |
$2K |
| 74018 |
|
588 |
543 |
$2K |
| 73562 |
|
334 |
272 |
$1K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
594 |
531 |
$1K |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
726 |
652 |
$1K |
| 82962 |
|
840 |
729 |
$1K |
| 11102 |
|
30 |
29 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16 |
16 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
125 |
112 |
$1K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
394 |
328 |
$1K |
| 99406 |
|
211 |
102 |
$975.03 |
| 87400 |
|
2,392 |
818 |
$891.92 |
| 73030 |
|
249 |
218 |
$855.98 |
| 99173 |
|
95 |
77 |
$800.16 |
| 72100 |
|
226 |
207 |
$785.75 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
606 |
466 |
$730.53 |
| 97535 |
Self-care/home management training, each 15 minutes |
71 |
53 |
$584.01 |
| 99484 |
|
50 |
31 |
$583.53 |
| 90714 |
|
77 |
67 |
$525.04 |
| 99383 |
|
20 |
12 |
$504.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
374 |
282 |
$477.68 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
41 |
29 |
$476.64 |
| 72040 |
|
74 |
66 |
$414.88 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
442 |
390 |
$396.71 |
| 73560 |
|
122 |
111 |
$386.96 |
| 3008F |
|
11,054 |
9,488 |
$360.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
77 |
64 |
$254.32 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
305 |
250 |
$242.04 |
| 90756 |
|
31 |
27 |
$239.90 |
| 97014 |
|
46 |
12 |
$238.49 |
| 73140 |
|
248 |
232 |
$215.73 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
370 |
321 |
$210.58 |
| 95115 |
|
18 |
12 |
$199.20 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
49 |
44 |
$176.13 |
| 80061 |
Lipid panel |
278 |
213 |
$127.28 |
| 94760 |
|
110 |
59 |
$114.06 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
29 |
29 |
$100.00 |
| 80053 |
Comprehensive metabolic panel |
400 |
307 |
$91.93 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
389 |
302 |
$83.07 |
| 99499 |
|
4,486 |
3,709 |
$60.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15 |
12 |
$60.00 |
| 85018 |
|
16 |
14 |
$25.35 |
| 99000 |
|
603 |
531 |
$18.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
245 |
216 |
$12.71 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
97 |
89 |
$5.89 |
| 73590 |
|
28 |
25 |
$1.32 |
| 3725F |
|
39,580 |
34,123 |
$0.46 |
| 3351F |
|
31,163 |
27,039 |
$0.35 |
| 3353F |
|
737 |
595 |
$0.02 |
| S9083 |
Global fee urgent care centers |
487 |
427 |
$0.00 |
| 15853 |
|
79 |
71 |
$0.00 |
| 4004F |
|
118 |
77 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14 |
12 |
$0.00 |
| 3352F |
|
838 |
720 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
75 |
70 |
$0.00 |
| 4000F |
|
118 |
77 |
$0.00 |
| 3075F |
|
93 |
73 |
$0.00 |
| 73090 |
|
41 |
37 |
$0.00 |
| 3079F |
|
93 |
77 |
$0.00 |
| 90686 |
|
18 |
15 |
$0.00 |